Journalists from around the world were invited to join a media briefing webinar on the positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil.
Prof Andrew Pollard, Director of the Oxford Vaccine Group, Department of Paediatrics, University of Oxford
Prof Sarah Gilbert, Saïd Professorship of Vaccinology, Jenner Institute, Nuffield Department of Medicine, University of Oxford
Prof Louise Richardson, Vice Chancellor of the University of Oxford
Pascal Soriot, Chief Executive Officer, AstraZeneca
Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca
Pam Cheng, Executive Vice President, Operations and Information Technology, AstraZeneca
This Briefing was accompanied by and SMC Roundup of Comments.